What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
28/08/2024
Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der spanischen Behörde mitgeteilt, dass in Spanien, zusätzlich zu den bereits bekannt gegebenen Regionen, in der Provinz Huelva (Region Andalusien) sowie in der Provinz Badajoz (Region Extremadura) bestätigte humane WNV-Infektionen verzeichnet wurden.
Referenced at:
Posaconazole New
PSUR-outcome
|
23/08/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Recall
|
21/08/2024
Clinical investigations with medical devices Regulation on electronic submission Electronic Submission Form of the BASG General requirements for applications (technical validation) Clinical investigat
Atorvastatin New
PSUR-outcome
|
19/08/2024
Further information and amendments to the product information can be found on the EMA website.
Bumetanide New
PRAC signal recommendation
|
14/08/2024
Risko for toxic epidermal necrolysis and Stevens-Johnson syndrome. Further information and amendments to the product information can be found on the EMA website.
Acetazolamide New
PRAC signal recommendation
|
14/08/2024
Pulmonary oedemas. Further information and amendments to the product information can be found on the EMA website.
Minoxidil (topical formulation) New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Clevidipine New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Nimodipine New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Ceftazidime New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.